ARNA has a 1-year high of $2.16 and a 1-year low of $1.30. The stock’s 50-day moving average is $1.48 and …
Arena Pharmaceuticals
Stay Tuned! Disclosure: I am/we are long ARNA. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any …
Arena
Investors in Arena Pharmaceuticals Inc (Symbol: ARNA) saw new options become available today, for the February 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the …
NASDAQ
On Wednesday, ARNA stock jumped 60% on news that one of the drugs in its pipeline performed well as an autoimmune disease treatment in a Phase 1 trial. It’s not the sort of news most fans and followers of Arena …
Investors in Arena Pharmaceuticals Inc (NASD: ARNA) saw new options become available today, for the September 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the …
The orange points represent Arena Pharmaceuticals Inc's stock returns. The blue points represent INSYS …
INSYS
At the same time, VVUS closed at $5.78 with an only 2.48% increase. The comparison between the stock characteristics of both companies shows that they have a lot of similarities. The market value of ARNA is …
Arena Pharmaceuticals has been struggling to stay afloat as a company, especially with Belviq under performing in the obesity market. Thing are about to get worse because now it will have to go back to the drawing board. …
Stock